A randomized, phase 3, open-label trial comparing the effect of the addition of tirzepatide once weekly versus insulin lispro (U100) three times daily in participants with type 2 diabetes inadequately controlled on insulin glargine (U100) with or without metformin (SURPASS-6)
( A ) ATP generation and ( B ) intracellular cAMP accumulation were analyzed as detailed in the Supplemental Methods from WT sAC +/+ caSMCs incubated for 10 minutes with 0.1 nM to 1 M GLP-1(2836) or scrambled control
As of 2026, the FDA allows licensed pharmacies to make these peptides with a prescription, but that is not the same as approving them as safe or effective
The career cost: Research consistently shows that fatigue, reduced mobility, and weight-related health issues decrease productivity and increase absenteeism
Chicken breast, fish, eggs, and Greek yogurt are good choices